Buy VNDA by Mar 14, 2026.

We've all seen those huge spikes in SP and they're usually biotechs who have had favourable trial results or FDA approval. So I've taken time to look into various companies with potential milestone events this month. The single stockpick I have come up with is Vanda Pharma (VNDA) which is a small-cap biotech with a growing commercial foundation. Already has sales momentum with Fanept and recent approval of Nereus trapitant for motion sickness, which triggered strong stock moves late last …